Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysis
<h4>Background</h4> Chronic atrophic gastritis is a significant premalignant lesion of gastric carcinoma. There is a great need to prevent the progression to gastric carcinoma through early intervention and treatment for chronic atrophic gastritis. Weifuchun, a famous Chinese patent drug...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101393/?tool=EBI |
| _version_ | 1797846143083741184 |
|---|---|
| author | Longhua Wang Xia Ding Ping Li Fuwen Zhang Shuying Ru Fenglei Wang Lan Li |
| author_facet | Longhua Wang Xia Ding Ping Li Fuwen Zhang Shuying Ru Fenglei Wang Lan Li |
| author_sort | Longhua Wang |
| collection | DOAJ |
| description | <h4>Background</h4> Chronic atrophic gastritis is a significant premalignant lesion of gastric carcinoma. There is a great need to prevent the progression to gastric carcinoma through early intervention and treatment for chronic atrophic gastritis. Weifuchun, a famous Chinese patent drug, has been widely used for chronic atrophic gastritis in China. However, it remains unclear whether Weifuchun is effective for atrophic gastritis. <h4>Objective</h4> To determine the effectiveness and safety of Weifuchun for chronic atrophic gastritis. <h4>Methods</h4> We systematically retrieved seven databases (Cochrane Library, EMBASE, PubMed, China National Knowledge Infrastructure, Wanfang database, Chinese Scientific Journals Database, and Chinese Biological Medical Database) from their inception to October 5, 2022. Methodological quality was examined using the Cochrane Risk of bias tool. We also used RevMan 5.4 software for statistical analysis to examine the effectiveness and safety of Weifuchun. <h4>Results</h4> Fifteen studies with 1,488 patients were enrolled in this meta-analysis. The study indicated that Weifuchun was more effective (RR 1.52; 95% CI 1.41, 1.63; p<0.00001) than Western medicine and other Chinese patent medicine. In addition, Weifuchun was more effective in improving gastric mucosal under gastroscopy, improving histopathologic changes of gastric mucosal, and inhibiting Helicobacter pylori. However, no significant difference in safety was examined between Weifuchun and the control group (RR 2.83; 95% CI 0.85, 9.38; P = 0.09). <h4>Conclusions</h4> The meta-analysis revealed a significant statistical difference with Weifuchun in effectiveness compared to the control group. However, there was no significant difference in safety. Thus, more high-quality clinical studies are needed in the future. <h4>Trial registration</h4> Registration number CRD42022365703. |
| first_indexed | 2024-04-09T17:50:10Z |
| format | Article |
| id | doaj.art-369a43541e884b3caceda9465d50cdf5 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-09T17:50:10Z |
| publishDate | 2023-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-369a43541e884b3caceda9465d50cdf52023-04-16T05:31:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01184Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysisLonghua WangXia DingPing LiFuwen ZhangShuying RuFenglei WangLan Li<h4>Background</h4> Chronic atrophic gastritis is a significant premalignant lesion of gastric carcinoma. There is a great need to prevent the progression to gastric carcinoma through early intervention and treatment for chronic atrophic gastritis. Weifuchun, a famous Chinese patent drug, has been widely used for chronic atrophic gastritis in China. However, it remains unclear whether Weifuchun is effective for atrophic gastritis. <h4>Objective</h4> To determine the effectiveness and safety of Weifuchun for chronic atrophic gastritis. <h4>Methods</h4> We systematically retrieved seven databases (Cochrane Library, EMBASE, PubMed, China National Knowledge Infrastructure, Wanfang database, Chinese Scientific Journals Database, and Chinese Biological Medical Database) from their inception to October 5, 2022. Methodological quality was examined using the Cochrane Risk of bias tool. We also used RevMan 5.4 software for statistical analysis to examine the effectiveness and safety of Weifuchun. <h4>Results</h4> Fifteen studies with 1,488 patients were enrolled in this meta-analysis. The study indicated that Weifuchun was more effective (RR 1.52; 95% CI 1.41, 1.63; p<0.00001) than Western medicine and other Chinese patent medicine. In addition, Weifuchun was more effective in improving gastric mucosal under gastroscopy, improving histopathologic changes of gastric mucosal, and inhibiting Helicobacter pylori. However, no significant difference in safety was examined between Weifuchun and the control group (RR 2.83; 95% CI 0.85, 9.38; P = 0.09). <h4>Conclusions</h4> The meta-analysis revealed a significant statistical difference with Weifuchun in effectiveness compared to the control group. However, there was no significant difference in safety. Thus, more high-quality clinical studies are needed in the future. <h4>Trial registration</h4> Registration number CRD42022365703.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101393/?tool=EBI |
| spellingShingle | Longhua Wang Xia Ding Ping Li Fuwen Zhang Shuying Ru Fenglei Wang Lan Li Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysis PLoS ONE |
| title | Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysis |
| title_full | Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysis |
| title_fullStr | Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysis |
| title_full_unstemmed | Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysis |
| title_short | Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysis |
| title_sort | efficacy and safety of weifuchun tablet for chronic atrophic gastritis a systematic review and meta analysis |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101393/?tool=EBI |
| work_keys_str_mv | AT longhuawang efficacyandsafetyofweifuchuntabletforchronicatrophicgastritisasystematicreviewandmetaanalysis AT xiading efficacyandsafetyofweifuchuntabletforchronicatrophicgastritisasystematicreviewandmetaanalysis AT pingli efficacyandsafetyofweifuchuntabletforchronicatrophicgastritisasystematicreviewandmetaanalysis AT fuwenzhang efficacyandsafetyofweifuchuntabletforchronicatrophicgastritisasystematicreviewandmetaanalysis AT shuyingru efficacyandsafetyofweifuchuntabletforchronicatrophicgastritisasystematicreviewandmetaanalysis AT fengleiwang efficacyandsafetyofweifuchuntabletforchronicatrophicgastritisasystematicreviewandmetaanalysis AT lanli efficacyandsafetyofweifuchuntabletforchronicatrophicgastritisasystematicreviewandmetaanalysis |